INTELLIGENT BIO SOLUTIONS IN (INBS)

Company Profile

Intelligent Bio Solutions, Inc. operates as a biosensor diagnostic technology company. The company is headquartered in New York City, New York and currently employs 51 full-time employees. The company went IPO on 2020-12-23. The firm is engaged in developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. The company operates through two segments, namely Commercially available Intelligent Fingerprinting Products (IFPG) and Development Stage Saliva Glucose Biosensor Platform (SGBP). Its product portfolio includes a portable drug screening system that works by analyzing fingerprint sweat using a one-time cartridge and portable handheld reader and also includes a development stage range of biosensor- based Point of Care diagnostic tests (POCT) that are developed in the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology. Its product candidate is the Saliva Glucose Biosensor (SGB), a POCT expected to substitute the finger pricking invasive blood glucose monitoring for diabetic patients. Its Biosensor Platform helps to detect multiple biological analytes.

Company Info

INTELLIGENT BIO SOLUTIONS IN

142 West 57Th St Fl11

New York City NEW YORK

P: 16462336971

Employees: 51

Website: https://gbs.inc/